Omega Q2 2025: AFFO per share $0.77 vs $0.71 YoY; raises FY guidance; $527M invested

OMEGA HEALTHCARE INVESTORS INC

2025-Q2 EPS reported $0.79 revenue$559,291,000

Net income $140M ($0.46/shr) vs $117M ($0.45/shr) in Q2 2024.
Adjusted FFO $232M ($0.77/shr) vs $185M ($0.71/shr); weighted avg shares 303M vs 262M.
Completed $527M in new investments ($502M acquisitions, $25M loans) in Q2.
Issued $600M of 5.2% senior unsecured notes due 2030; extended credit facility to Oct 2025.
Raises full-year adjusted FFO guidance (specific range not provided in filing snippet).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.